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Abstract
Background: An intricate gene regulatory network drives neural crest migration and differentiation. How epigenetic
regulators contribute to this process is just starting to be understood.
Results: We found that mutation of med14 or brg1 in zebrafish embryos resulted in a cluster of neural crest cell-related
defects. In med14 or brg1 mutants, neural crest cells that form the jaw skeleton were specified normally and migrated
to target sites. However, defects in their subsequent terminal differentiation were evident. Transplantation
experiments demonstrated that med14 and brg1 are required directly in neural crest cells. Analysis of med14;
brg1 double mutant embryos suggested the existence of a strong genetic interaction between members of
the Mediator and BAF complexes.
Conclusions: These results suggest a critical role for Mediator and BAF complex function in neural crest
development, and may also clarify the nature of defects in some craniofacial abnormalities.
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Background
The neural crest lineage is a multi-potent, migratory
population that is unique to vertebrate embryos and
gives rise to a diversity of cell types including melano-
cytes, craniofacial cartilage and bone, smooth muscle,
peripheral and enteric neurons and glia [1]. The specifi-
cation, migration and differentiation of neural crest cells
are tightly coordinated during development, with defects
in these processes leading to a number of congenital dis-
eases [2]. There is good evidence that during vertebrate
embryogenesis a highly conserved neural crest gene
regulatory network (GRN) orchestrates transcriptional
events that are critical for various steps of neural crest
development [3]. In addition to transcriptional regula-
tion, mounting evidence supports a critical role for
epigenetic regulation in neural crest development, most
notably by controlling the timing of gene expression
during this process [4].
Mediator is an evolutionarily conserved, multi-protein
complex that is a key regulator of RNA polymerase II-
mediated transcription [5]. In metazoan cells, multiple
pathways that are responsible for homeostasis, cell growth
and differentiation converge on Mediator through tran-
scriptional activators and repressors that target one or
more of the 30+ subunits of this complex [6]. Besides
RNA polymerase II, Mediator interacts with and coordi-
nates the action of numerous additional transcriptional
regulators, including those acting at the level of chromatin
remodeling [7, 8]. However, while in vitro data indicates
the interaction between Mediator and chromatin remode-
lers, there is little in vivo data to support this hypothesis.
Med14 is a subunit of Mediator that is essential for
incorporation of the Tail module into Mediator [6, 9]. We
have recently shown that Med14 plays an essential role in
vertebrate embryogenesis and stem cell maintenance [10].
Working as a multi-subunit cellular machine that
consumes ATP to modify DNA-histone contacts and
modulate chromatin compaction, the BAF (BRG1/BRM-
associated factors) complex plays a key role in many
developmental processes by modulating gene expression.
This further occurs via interaction of the BAF complex
with transcription factors and other epigenetic readers at
promoters and enhancers [11]. The BAF complex includes
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one of two core ATPases, Brm or Brg1, as well as a num-
ber of other subunits. Brm is dispensible for mouse devel-
opment, whereas Brg1 (Smarca4) is essential for broad
aspects of embryogenesis [12, 13]. Differential inclusion of
other subunit variants can give novel functions to the BAF
complex in processes including neuronal development
and cardiogenesis [11, 14, 15]. Reports have demonstrated
a role for the Mediator complex in recruitment of the
BAF complex to promoters or enhancers of target genes
[16, 17], however no in vivo evidence for this genetic
interaction and its importance exist to date. Defects in
neural crest cell-derived tissues has been noted in brg1
mutants [18] and recent work has shown that the BAF
complex co-operates with CHD7 to orchestrate the ex-
pression of genes that regulate the migration of neural
crest cells [19]. However, the mechanism underlying these
roles in neural crest development has to date not been
well characterized.
In the present study, we sought to determine the roles
of med14 and brg1 during neural crest cells differenti-
ation, and examine any possible genetic interactions. We
found that med14 mutant zebrafish embryos demon-
strated multiple neural crest cell-related defects. Further
analysis indicated that specification and early migration
of neural crest cells occurred normally in med14 mu-
tants, with neural crest cells of the jaw subsequently fail-
ing to undergo terminal differentiation at their target
sites. We further found that mutation of brg1 also re-
sulted in similar abnormalities. Analysis of med14 and
brg1 double mutant embryos revealed strong genetic
interactions between the Mediator and BAF complexes.
Based on transplantation analysis, we found that both
med14 and brg1 function in neural crest cells differenti-
ation in a cell-autonomous fashion. Taken together, our
results indicate that the BAF and Mediator complexes
play essential and overlapping roles in the terminal steps
of neural crest differentiation.
Results
In unrelated studies, we noticed that zebrafish log (a null
allele for med14) [10] and young (a null allele for brg1)
[14] mutants shared a common array of deficiencies in
heart, eye, pectoral fin and pigment cell development
(Fig. 1a–d and data not shown). This similarity sug-
gested overlapping or common functions for med14 and
brg1. To test this possibility, double mutants were gener-
ated. The med14; brg1 double mutant embryos displayed
a much more severe phenotype compare to single mu-
tants, including a curved body axis, smaller eyes, severe
heart edema and loss of pigment (Fig. 1a). To further in-
vestigate the role of med14 and brg1 in development, as
well as possible functional interactions between the
Mediator and BAF complexes, neural crest cell-derived
tissues were analyzed in various mutant backgrounds. In
med14 and brg1 single mutants, the melanin in melano-
cytes showed a less even and spiky distribution com-
pared to controls; whereas in med14; brg1 double
mutants melanin distribution took on a small, rounded
appearance (Fig. 1b–e). Quantification of melanocyte
number on the dorsal surface of the trunk revealed no
significant differences between controls and mutants
(Fig. 1q, P = 0.94).
The development of the neurocranium and viscerocra-
nium were next analyzed through Alcian blue staining at
96 h post-fertilization (hpf). In brg1 mutants, the neuro-
cranium was dismorphic, and the size of Meckel’s cartil-
age, ceratohyal and palatoquadrate on the viscerocranium
were greatly reduced, with the last two branchial arches
absent (Fig. 1j–k and n–o). In med14 mutants, trabeculae
formed, while most of the ethmoid plate and lateral parts
of parachordal plate were not evident (Fig. 1l). Aside from
relics of palatoquadrate, viscerocranium structures were
absent in med14 mutants (Fig. 1p). In med14; brg1 double
mutants, only posterior portions of trabeculae and para-
chordal plate were apparent, whereas viscerocranium was
completely absent (Fig. 1m). It has been reported some
posterior elements (part of trabeculae and parachodal
plate) are derived from mesoderm [20]. As these elements
remained in med14; brg1 double mutants, this suggested
med14 and brg1 are only required for neural crest-derived
cartilage.
To further explore genetic interactions between med14
and brg1, we examined cartilage defects in brg1−/−;
med14+/− and med14−/−; brg1+/− embryos. In either
case, further loss of one allele of med14 or brg1 in either
brg1 or med14 null mutants resulted in more severe de-
fects in facial cartilage formation as compared to single
mutants (Fig. 1r–t). We also observed that med14 and
brg1 mutants shared a common array of deficiencies in
heart, eye and otic vesicle development. At 48 hpf, eye,
otic vesicle and heart defects in med14 or brg1 mutant
embryos were similarly exacerbated in med14/brg1 double
mutants (data not shown). Taken together, these data
showed that zebrafish med14 or brg1 mutants displayed
defects in neural crest-derived cells and tissues such
like craniofacial cartilage and melanocyte. Furthermore,
med14; brg1 double mutants, or single mutants where one
allele of the other gene was lost, displayed a more severe
phenotype than single mutants, suggesting overlapping
functions of the Mediator and BAF complexes.
As the phenotypes observed in med14 and brg1 mu-
tants involved multiple tissues and developmental stages,
we subsequently focused our analysis on jaw cartilage
development to uncover the mechanisms of med14 and
brg1 function in neural crest development. Neural crest
specification was first analyzed via expression of foxd3,
sox9b and snail1b, which are expressed in pre-migratory
neural crest at the dorsal side of neural tube at 14 hpf
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Fig. 1 Multiple neural crest-derived phenotypes in mutant embryos. a Images of embryo morphology at 72 hpf. b to e Melanocyte defects in
mutants at 48 hpf. Dorsal view with anterior to top. Scale bars, 1 mm. j to p and r to t) Alcian blue staining of cartilage reveals defects in neurocranium
and viscerocranium formation in mutant embryos at 96 hpf. At least 15 embryos for each genotype were analyzed and representative samples are
showed. Compared to single brg1 or med14 mutants, embryos bearing an additional copy of med14 or brg1 null allele show a more severe phenotype.
Ventral view with anterior to the top. bh, basihyal; cb, ceratobranchial; ch, ceratohyal; ep, ethmoid plate; hs, hyosymplectic; m, Meckel’s cartilage; pc,
parachordal plate; pq, palatoquadrate; tr, trabeculae. q Quantification of melanocyte number at 48 hpf on the trunks of control and mutant embryos.
Twelve embryos for each genotype were counted. Error bars represent the SD
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[21]. No overt difference in expression was apparent
between control and mutant embryos (Fig. 2a–l), indi-
cating that neural crest cells were properly specified in
med14, brg1 and med14; brg1 mutants. Subsequent
migration of neural crest cells was studied via use of a
neural crest-specific sox10:EGFP transgenic line [22].
Neural crest cells in all three mutant backgrounds
dispersed and migrated around the eye and optic stalk to
reach the oral ectoderm and formed primodia of bran-
chial arches by 24 hpf; with the behavior of neural crest
cells being similar between mutant and control embryos
(Fig. 3a and d). In situ hybridization also showed that
markers of migratory facial neural crest, dlx2a and
twist1a, were expressed normally in mutants at 18 hpf
(Fig. 3b–c).
To determine if postmigratory cranial neural crest was
properly maintained in these mutants, we examined ex-
pression of sox9a, dlx3b and hand2, which function in
neural crest differentiation [23, 24], at 32 hpf. The ex-
pression of sox9a and dlx3b were both down-regulated
in med14 and brg1 single mutants, and almost abolished
in med14; brg1 double mutants (Fig. 3e–f ). At 30 hpf,
hand2 clearly marks rings of ventral neural crest in the
pharyngeal arches (Fig. 3g). In med14 and brg1 mutant
embryos, the expression of hand2 was reduced (Fig. 3g).
In med14; brg1 double mutants, the expression was
largely abolished except for in a small patch posterior to
the eyes, which was maintained. Notably, hand2 ex-
pression in the heart tube remained in double mu-
tants, indicating that the regulation of hand2 by brg1
and med14 is neural crest-specific (Fig. 3g). During
jaw development, neural crest cells undergo extensive
proliferation, so it is possible the defects observed in
mutants were due to impaired cell proliferation or
enhanced cell death. Cell proliferation and cell death
were therefore analyzed at 36 hpf, however no obvious
differences between control and mutants was observed
(Fig. 4, P = 0.94 for cell proliferation and P = 0.95 for cell
death). Taken together, this data suggests that in mutants
neural crest cells are formed and migrate properly, but are
subsequently unable to initiate a differentiation program
towards becoming skeletogenic ectomesenchyme.
Neural crest differentiation depends both on intrinsic
gene regulatory programs and signals from the sur-
rounding environment [25]. As such, deficiencies either
in neural crest cells themselves or other tissues could be
responsible for the defects we observed in brg1 and
med14 mutants and compound mutants. As signals from
the endoderm and notochord are indispensable for the
migration and differentiation of pharyngeal neural crest
cells [26, 27], we first analyzed expression of foxa1 and
shh, which are markers of these two tissues, at 30 hpf.
Both genes showed apparently normal expression in
mutants and compound mutants, suggesting that these
tissues were not grossly abnormal (Fig. 5a–d and e–h).
Since endodermal pouches play important role in pat-
terning and differentiation of pharyngeal arches [28], we
analyzed expression of nkx2.3 and tbx1, which are
expressed in both the pre-pouch endoderm and sur-
rounding mesoderm [29]. At 32 hpf, expression of
nkx2.3 and tbx1 appeared normal in both wild type and
mutant embryos (Fig. 5 i to l and m to p), suggesting
Fig. 2 Neural crest cells are specified normally in mutant embryos. a to l: At 10 somite stage (14 hpf), expression of the neural crest specification
markers foxd3, sox9b and snail1b were probed by RNA in situ hybridization. At least 20 embryos for each genotype were analyzed and representative
samples are showed. Dorsal views with anterior to the top
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that induction of the endodermal pouches is not
dependent on med14 or brg1 function.
To directly examine the cellular autonomy of med14
and brg1 function, we employed a transplantation ap-
proach. Cells were first taken from the animal pole of 4
hpf wild type sox10:EGFP donor embryos and trans-
ferred to the equivalent location in wild type or mutant
4 hpf host embryos (Fig. 6a). Based on their localization
in the host embryo, a proportion of these naïve cells will
normally take on a cranial neural crest fate in these
experiments, as indicated by donor cell GFP expression.
We observed that in all cases wild type donor GFP-
positive neural crest cells in either wild type (n = 33) or
mutant (med14−/−: n = 26; brg1−/−: n = 24; med14; brg1
double mutant: n = 11) host embryos migrated to oral
ectoderm and formed cartilage clusters, (Fig. 6f–i). Strik-
ingly, as assayed by cartilage staining, we found that wild
type donor cells could rescue anterior neurocranium
cartilage phenotypes in med14 (43 %, n = 34) and med14;
brg1 double mutant embryos (31 %, n = 14) (Fig. 6j–m).
When sox10:EGFP activity was compared to cartilage
staining results from the same embryos, we observed
that anterior neurocranium cartilage entirely matched to
GFP-positive clusters (Fig. 6g and k), strongly suggesting
that wild type donor cells acted as the source of
the cartilage.
To further examine the fate of med14 and brg1 mutant
neural crest cells, transplantation experiments were next
carried out in which wild type or mutant sox10:EGFP
donor embryos were injected with rhodamine-dextran to
allow observation of all donor cells (regardless of neural
crest fate) (Fig. 7a). In wild type hosts, GFP-positive sin-
gle or double brg1 and med14 mutant donor cells were
observed that migrated to oral ectoderm at 24 hpf (Fig. 7
c, g, k and o). At 72 hpf, in 54 % of control (wild type
donor, n = 44) transplantation experiments, donor cells
were observed contributing to cartilage (Fig. 7d–f ). In
the case of brg1 mutant donor cells, 11 % of transplants
showed a contribution to cartilage (n = 31, Fig. 7h–j),
with GFP-positive cells displaying abnormal cell shape
Fig. 3 Defects in skeletogenic neural crest differentiation in the jaw forming area of med14 and brg1 mutant embryos. a to d Neural crest cells
migrated to the oral ectoderm in both control and mutant embryos. a Snapshot of migrating neural crest cells (marked by sox10:EGFP transgene)
in control and mutant embryos at 15 somite stage. b and c The migrating neural crest expressed dlx2a and twist1a at 18 somite stage. d At 24
hpf, neural crest cells reached the brachial arches forming region and condensed. a and d: lateral view with dorsal to top and anterior to left.
e to g The mutants showed mis-expression of genes involved in mesenchymal condensations and chondrocyte differentiation. b, c, e, f and g
RNA in situ hybridization is shown for expression of dlx2a, tiwst1a, sox9a, dlx3b and hand2. At least 15 embryos for each genotype were analyzed
and representative samples are shown. Hollow arrowheads indicate pharyngeal arches; red arrowhead in g indicates the heart tube of embryo.
Lateral views with anterior to the left. Scale bars, 100 um
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(compared to the elongated cuboidal shape observed in
control transplants (Fig. 7d and h). Strikingly, in none
of the transplants where med14 (n = 37) or med14;
brg1 (n = 21) mutant donor cells were used was con-
tribution to cartilage noted (based on GFP expres-
sion). However, imaging of the donor cell lineage
tracer (rhodamine-dextran) showed that mutant cells
still survived in the jaw region of wild type hosts
(Fig. 7l–n and p–r). These experiments indicated that
both med14 and brg1 function cell autonomously in
neural crest cells, to govern proper skeletogenic ecto-
mesenchyme differentiation. Further, the persistence
of the lineage label in mutant donor cells, despite the
absence of cartilage formation, argues for a model where
med14 and brg1 are required subsequent to migration of
neural crest cells, where they are necessary to the
Fig. 4 No apparent alterations in cell proliferation and cell death in arch-forming regions of mutant embryos. a to l Cell proliferation at 36 hpf
was analyzed through BrdU incorporation. Neural crest cells were marked by sox10:EGFP transgene and revealed by immunostaining with
anti-GFP antibody. Proliferating cells were marked by BrdU then revealed by immunostaining with anti-BrdU antibody. Lateral views with
anterior to left. m to t Cell death at 36 hpf was analyzed through TUNEL assay. Lateral views with anterior to left. u Quantification of BrdU-positive cell
in 2nd arch (dotted squares in a, d, g and j) in control and mutant embryos. Bars represent the SD. v Quantification of TUNEL positive cell in one side
of pharyngeal arches in control and mutant embryos at 36 hpf. Bars represent the SD. Scale bars, 100 um
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initiation of chondrocyte differentiation. In the absence of
this activity, neural crest differentiation to cartilage, and
jaw development, is severely perturbed.
Discussion
At different developmental stages, Mediator and BAF
complexes influence a wide variety of biological pro-
cesses. The nature of their activity is context dependent,
and in many cases involves differential use of variant
complex member subunits to confer different activities
[11]. It will be interesting to investigate, specifically in
the scenario of neural crest development, how these two
complexes function in a tissue and developmental stage
specific manner and how the genetic interactions revealed
in this study are executed. An intriguing possibility is that
subunit(s) of these two complexes act cooperatively to
regulate the expression of genes critical for terminal differ-
entiation of craniofacial neural crest cells. As neural crest
contributes to a great diversity of additional cell types, and
defects were observed in multiple neural crest-derived
tissues in med14 and brg1 mutants, more specific
analysis of defects in these cell types, and determining
which genes are directly regulated by the Mediator
and BAF complexes, will be of great interest. Further,
while we have described defects in the maintenance
of neural crest fate or terminal differentiation in this
study, the actual fate of these cells is not clear. Or results
suggest these cells are not lost via apoptosis. It will be of
interest to determine if they adopt an alternative cell fate,
and if so what this fate(s) and what mechanisms underlie
this fate conversion may be.
In a previous report [19], knock down of brg1 by mor-
pholino injection in frog embryos led to defects in
neural crest migration. Our data, however, suggests that
the initial specification and early migration of cranial
neural crest occurs normally even in severely affected
brg1; med14 double mutants, which is then followed by
defects in skeletogenic neural crest differentiation from
30 hpf onwards. Furthermore, by using transplantation
approaches, we have shown that med14 and brg1 act cell
autonomously (in neural crest) to regulate differentiation
of these cells. These discoveries reveal an unexpected
mechanism in facial cartilage development, which has
been previously ascribed to defects in migration of
neural crest cells to the site of differentiation, and raises
a possible mechanism underlying the symptoms of
Fig. 5 Mesoderm of pharyngeal arches and endodermal pouches are not affected in mutants. a to d: Expression of foxa1 at 32 hpf in pharyngeal
endoderm. e to h: The expression of shh in the stomodeum epithelium at 48 hpf. i to l: At 36 hpf, expression of the endodermal pouches marker
nkx2.3. m to p: At 36 hpf, expression of the pharyngeal arches mesoderm marker tbx1. a to d and i to l, dorsal view with anterior to the top.
e to h and m to p, lateral view with anterior to the left
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neural crest-related diseases, including CHARGE syn-
drome. It should be noted that these previous studies
were largely based on use of morpholino oligonucleo-
tides, whereas our current work uses genetic mutants
for analysis. The brg1 mutant used in this study [14] is a
strong null allele, and phenocopies other described brg1
mutants [18]. We have recently described three novel
med14 mutant alleles [10], with the s231 allele used in
this study having an equivalent phenotype to the m628
allele that results in pronounced loss of transcript by
nonsense-mediated decay. It is possible the maternally
deposited (wild type) Brg1 and Med14 protein or tran-
script mask early effects on neural crest development in
zebrafish mutants. However, as initial neural crest speci-
fication and migration appeared roughly normal even in
double brg1; med14 mutants, this seems unlikely.
Development of the neural crest is of exceptional med-
ical importance, being affected in a large percentage of
congenital defects. The results presented in this study
and other recent publications show that the Mediator
complex may contribute to a range of neural crest
cell-related craniofacial abnormalities. The patients with
CHARGE syndrome, a neural crest cell-related congenital
anomaly, present a cluster of malformations in craniofa-
cial, peripheral nervous system, ear, eye and heart [30]. Re-
cent work has shown that the BAF complex orchestrates
the development of neural crest cells via co-operating with
CHD7 [19], which is mutated in the majority of CHARGE
syndrome cases [31]. Attempting to identify mutations
affecting Mediator complex components in CHARGE
syndrome and other neural crest-related patients will be
helpful to further illustrate the molecular etiology of these
syndromes. A more detailed analysis of mutant models of
neural crest-derived craniofacial (and other) defects is also
clearly warranted. Generation and analysis of chd7 mutant
zebrafish, for example, will be of great interest.
Conclusions
In this study we used genetic tools to analyze the func-
tion and interaction of Mediator and BAF complexes on
Fig. 6 Wild type neural crest can contribute to jaw cartilage in mutant host. a Schematic diagram of the transplantation approach. Wild type
sox10:EGFP transgenic donor cells are transplanted to the animal pole of wild type or mutant host embryos at 4 hpf. b to e At 24 hpf, donor-derived neural
crest migration to the oral ectoderm is evident regardless of host genotype. Lateral views with anterior to the top. f to i At 72 hpf, donor-derived neural
crest persistence and differentiation to cartilage is evident regardless of host genotype. Ventral views with anterior to the top. j tom At 72 hpf, cartilage
staining reveals wild type donor-derived cells partially rescuing anterior neurocranium defects in med14 and med14; brg1 double mutant
embryos. g and k represent images from the same embryo. Red arrowheads indicate cartilage derived from wild type donor cells; black arrowheads
indicate host cell-derived cartilage. Dorsal views with anterior to the top. Scale bars, 100 um
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neural crest development. We found that mutation of
med14 or brg1 in zebrafish embryos led a cluster of
neural crest cell-related defects. Further analysis revealed
additive genetic interactions between med14 and brg1,
resulting in more severe defects. These defects appar-
ently arise not from an absence of neural crest at the site
of cartilage development, but a failure of these cells to
properly execute terminal differentiation into jaw cartilage
Fig. 7 Cell autonomous requirement for med14 and brg1 in neural crest cells for cartilage differentiation. a Schematic diagram of transplantation
approach. Donor (wild type or mutant) sox10:EGFP transgenic embryos were injected with rhodamine-dextran lineage tracer and transplanted to
the animal pole of wild type host embryos at 4 hpf. b Diagram showed the region was imaged at 80 hpf. c, g, k and o At 24 hpf, donor-derived
neural crest migration to the oral ectoderm is evident regardless of donor genotype. Later views with anterior to the top. d, e and f; h, i and j;
l, m and n; p, q and r Donor cell contribution to cartilage assayed at 80 hpf. Ventral views with anterior to the top. D’ and H’: higher magnificent
views of regions indicated by red squares in b and e. Scale bars, 100 um
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elements. The genetic interaction between brg1 and
med14 revealed in this present study indicates that
Mediator complex function might act as an additional
potential modifier in human congenital jaw defects.
Methods
Zebrafish lines and imaging
Zebrafish embryos were maintained and staged
using standard techniques [32]. Tg(sox10:EGFP)ir937,
Tg(myl7:EGFP)twu34 and brg1s481 fish have been previ-
ously described [22, 33, 34]. The brg1s481 allele was identi-
fied in a diploid ENU mutagenesis screen for mutations
affecting endodermal organ morphogenesis [33]. A C-to-T
base-pair change at position 754 in the brg1 (smarca4)
coding sequence creates a premature STOP codon at
amino acid 252. The med14s231 allele was first recovered
from a screen for cardiovascular mutants [35], and results
in a premature STOP codon at amino acid 1200 in the
Med14 coding sequence [10]. The s231 allele acts as a
null, phenocopying the m628 allele in which mutant tran-
script levels are greatly reduced by nonsense-mediated
decay. Imaging was performed using a Leica DFC320
camera on a Leica M205FA stereomicroscope. All
confocal images were taken with Zeiss LSM510 con-
focal microscope.
RNA probes transcription and RNA in situ hybridization
Transcription of DIG-labeled antisense RNA probes
was performed using standard methods. RNA in situ
hybridization (ISH) was carried out as previously de-
scribed [36].
Cartilage staining
Alcian Blue stainng was performed as previously
described [37].
Melanocyte counts
At 120 hpf, larvae were incubated in 10 mg/mL epineph-
rine (diluted in embryo media), anesthetized in tricaine
and fixed in 4 % paraformaldehyde at room temperature
for 2 h. Larvae were positioned on a spot plate using
3 % methyl cellulose to facilitate counting. Melanophore
counts in all experiments included the dorsal (head,
trunk and tail) lateral stripes.
Cell proliferation and cell death assays
BrdU incorporation analysis and cell death assay were
performed as previously described [38, 39]. Anti-GFP
antibody from Abcam was used to label neural crest
cells after HCl treatment. Cell death was assayed with a
Cell Death Assay Detection Kit, POD (Roche), based on
labeling of DNA strand breaks (TUNEL technology).
Transplantation
Transplantation experiments were carried out as previ-
ously described [32, 40]. Donor and host embryos were
subsequently kept in the same positions in a transplant
mold until 48 hpf, when donor genotyping was carried
out. For lineage tracing experiments, donor embryos were
injected with 2 nl of 5 % tetramethylrhodamine dextran
(10,000 MW, Molecular Probes) at the one-cell stage.
Ethics approval
Zebrafish were housed and handled as per Canadian
Council on Animal Care and Hospital for Sick Children
Laboratory Animal Services guidelines.
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